These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7941335)

  • 21. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
    Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
    Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between homologies of E2/NS1 gene from genotype III Chinese isolates of hepatitis C virus and that from reported isolates.
    Wu C; Tao Q
    Chin Med J (Engl); 1998 Sep; 111(9):807-9. PubMed ID: 11155671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in hypervariable region 1 quasispecies between immune complexed and non-immune complexed hepatitis C virus particles.
    Korenaga M; Hino K; Okazaki M; Okuda M; Okita K
    Biochem Biophys Res Commun; 1997 Nov; 240(3):677-82. PubMed ID: 9398625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody-free virion titer greatly differs between hepatitis C virus genotypes.
    Kimura Y; Hayashida K; Ishibashi H; Niho Y; Yanagi Y
    J Med Virol; 2000 May; 61(1):37-43. PubMed ID: 10745230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1.
    Lechner S; Rispeter K; Meisel H; Kraas W; Jung G; Roggendorf M; Zibert A
    Virology; 1998 Apr; 243(2):313-21. PubMed ID: 9568031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection.
    Bassett SE; Guerra B; Brasky K; Miskovsky E; Houghton M; Klimpel GR; Lanford RE
    Hepatology; 2001 Jun; 33(6):1479-87. PubMed ID: 11391537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental transmission of hepatitis C virus-associated fulminant hepatitis to a chimpanzee.
    Farci P; Munoz SJ; Shimoda A; Govindarajan S; Wong DC; Coiana A; Peddis G; Rubin R; Purcell RH
    J Infect Dis; 1999 Apr; 179(4):1007-11. PubMed ID: 10068599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of in vivo infectivity of hepatitis C virus to in vitro infectivity and to virion properties.
    Yoshikura H; Hijikata M; Nakajima N; Wang M; Mizuno K; Rikihisa T; Ueno T; Nishimura S; Shimizu Y
    Princess Takamatsu Symp; 1995; 25():139-42. PubMed ID: 8875618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses.
    van Doorn LJ; Capriles I; Maertens G; DeLeys R; Murray K; Kos T; Schellekens H; Quint W
    J Virol; 1995 Feb; 69(2):773-8. PubMed ID: 7815542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
    Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
    J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cell susceptibility to hepatitis C virus genotype 1 infection.
    Navas MC; Fuchs A; Schvoerer E; Bohbot A; Aubertin AM; Stoll-Keller F
    J Med Virol; 2002 Jun; 67(2):152-61. PubMed ID: 11992576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees.
    Bassett SE; Thomas DL; Brasky KM; Lanford RE
    J Virol; 1999 Feb; 73(2):1118-26. PubMed ID: 9882313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization.
    Farci P; Alter HJ; Wong DC; Miller RH; Govindarajan S; Engle R; Shapiro M; Purcell RH
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7792-6. PubMed ID: 7519785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential change of the hypervariable region of the hepatitis C virus genome in acute infection.
    Sakamoto N; Enomoto N; Kurosaki M; Marumo F; Sato C
    J Med Virol; 1994 Jan; 42(1):103-8. PubMed ID: 7508488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective transmission of hepatitis C virus genotypes and quasispecies in humans and experimentally infected chimpanzees.
    Nainan OV; Lu L; Gao FX; Meeks E; Robertson BH; Margolis HS
    J Gen Virol; 2006 Jan; 87(Pt 1):83-91. PubMed ID: 16361420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viruslike particles in a plasma fraction (fibrinogen) and in the circulation of apparently healthy blood donors capable of inducing non-A/non-B hepatitis in humans and chimpanzees.
    Yoshizawa H; Akahane Y; Itoh Y; Iwakiri S; Kitajima K; Morita M; Tanaka A; Nojiri T; Shimizu M; Miyakawa Y; Mayumi M
    Gastroenterology; 1980 Sep; 79(3):512-20. PubMed ID: 6776003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein.
    Farci P; Shimoda A; Wong D; Cabezon T; De Gioannis D; Strazzera A; Shimizu Y; Shapiro M; Alter HJ; Purcell RH
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15394-9. PubMed ID: 8986822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypervariable 5'-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants.
    Lesniewski RR; Boardway KM; Casey JM; Desai SM; Devare SG; Leung TK; Mushahwar IK
    J Med Virol; 1993 Jun; 40(2):150-6. PubMed ID: 7689636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal analysis of hepatitis C virus infection and genetic drift of the hypervariable region.
    van Doorn LJ; Quint W; Tsiquaye K; Voermans J; Paelinck D; Kos T; Maertens G; Schellekens H; Murray K
    J Infect Dis; 1994 Jun; 169(6):1226-35. PubMed ID: 7545928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.